Feature Channels: Personalized Medicine

Filters close
Newswise: Precision magnetics could be game-changer for therapy-resistant brain cancers
Released: 11-Apr-2023 1:45 PM EDT
Precision magnetics could be game-changer for therapy-resistant brain cancers
The Hospital for Sick Children

Scientists at The Hospital for Sick Children (SickKids) and the University of Toronto (U of T) have combined forces to develop a new approach to potentially treat tumour cells, called mechanical nanosurgery, even for aggressive, chemoresistant cancers.

Released: 11-Apr-2023 1:00 PM EDT
New Botox variant relieves nerve injury pain long-term, safely
University of Sheffield

A team of scientists from the Universities of Sheffield, Reading and University College London (UCL) and US-based biopharmaceutical company Neuresta have created a new, elongated botulinum neurotoxin which can alleviate chronic pain without risk of paralysis or addiction.

Newswise: ALS Center Celebrates Opening of New Practice Office
Released: 10-Apr-2023 3:50 PM EDT
ALS Center Celebrates Opening of New Practice Office
Hackensack Meridian Health

Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center recently celebrated the opening of the ALS Center’s new office in the Dr. Robert H. Harris Neuroscience Treatment Center. The center is one of only two Certified Treatment Centers of Excellence in New Jersey and is designated by the ALS Association’s National Office and the Greater Philadelphia Chapter.

Newswise: Study sheds light on how IBD can develop
Released: 7-Apr-2023 5:35 PM EDT
Study sheds light on how IBD can develop
University of California, Riverside

Inflammatory bowel disease, or IBD, describes Crohn’s disease and ulcerative colitis, two chronic diseases that cause inflammation in the intestines. IBD, which affects about 3 million adults in the United States, is an autoimmune disorder — a condition in which the body’s immune system attacks healthy tissues.

Newswise: Cedars-Sinai Guerin Children’s Sharpens Focus on Teen Health
Released: 7-Apr-2023 2:05 PM EDT
Cedars-Sinai Guerin Children’s Sharpens Focus on Teen Health
Cedars-Sinai

It has never been more challenging to be a teenager, says Michelle Escovedo, MD.

Released: 7-Apr-2023 1:10 PM EDT
New genetic finding provides clue for personalizing depression treatment
Medical University of South Carolina

A team of scientists at the Medical University of South Carolina (MUSC) has identified a stress-regulated gene that plays a role in the link between long-term stress and a common type of depressive behavior in mice.

   
Released: 6-Apr-2023 1:20 PM EDT
Optimizing sepsis treatment timing with a machine learning model
Ohio State University

A new machine learning model that estimates optimal treatment timing for sepsis could pave the way for support tools that help physicians personalize treatment decisions at the patient bedside, researchers say.

   
5-Apr-2023 6:05 AM EDT
Men and women have different obesity drivers, pointing to the need for tailored interventions
University of California, Los Angeles (UCLA), Health Sciences

A new study from UCLA researchers finds sex-specific brain signals that appear to confirm that different drivers lead men and women to develop obesity.

Newswise: IU neuroscientists lead new study laying groundwork for Alzheimer’s disease precision medicine
Released: 5-Apr-2023 2:15 PM EDT
IU neuroscientists lead new study laying groundwork for Alzheimer’s disease precision medicine
Indiana University

A 5-year, $41 million study will help researchers better understand the biological pathways underlying Alzheimer’s disease and ultimately create more personalized patient care through the development of a blood test for multiple pathways implicated in the disease – enabling earlier and less-invasive diagnosis.

Released: 4-Apr-2023 12:40 PM EDT
Penn Medicine Researchers Develop Model to Predict Cardiovascular Risk Among Chronic Kidney Disease Patients
Perelman School of Medicine at the University of Pennsylvania

Chronic kidney disease is a strong cardiovascular risk factor and is often accompanied by hypertension and diabetes. A new risk model for cardiovascular disease, developed by Penn, was found to be more accurate than existing clinical models.

Released: 3-Apr-2023 9:35 AM EDT
Yale-led Team Creates Comprehensive Resource for Impact of Genomic Variants
Yale Cancer Center/Smilow Cancer Hospital

Each person has about 4 million sequence differences in their genome relative to the reference human genome. These differences are known as variants. A central goal in precision medicine is understanding which of these variants contribute to disease in a particular patient.

Newswise: NYC Mayor Eric Adams Joined Top Biomedical Researchers to Usher in the Center for Engineering and Precision Medicine at Hudson Research Center at 619 West 54th Street
Released: 31-Mar-2023 11:15 AM EDT
NYC Mayor Eric Adams Joined Top Biomedical Researchers to Usher in the Center for Engineering and Precision Medicine at Hudson Research Center at 619 West 54th Street
Rensselaer Polytechnic Institute (RPI)

The grand opening of the Center for Engineering and Precision Medicine (CEPM), a partnership between Rensselaer Polytechnic Institute (RPI) and the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai), was held March 29, 2023 at the Hudson Research Center (HRC) at 619 West 54th Street. The center is the latest in a 10+ year partnership between RPI, a world-renowned technological research university known for its engineering, technology, and science programs, and Icahn Mount Sinai, the academic arm of the Mount Sinai Health System, which includes eight hospitals and a vast network of ambulatory practices throughout the greater New York City region.

Released: 28-Mar-2023 2:20 PM EDT
From the doctor's office to the operating room: Keep up with the latest in healthcare here
Newswise

From septic shock to sticker shock. Keep up with this ever-growing, changing sector. Below are some of the latest stories on healthcare on Newswise.

Released: 28-Mar-2023 10:05 AM EDT
$41 million federal grant to help Mayo Clinic, collaborators advance multiethnic Alzheimer’s research
Mayo Clinic

Alzheimer's disease affects people of all ethnic groups. Armed with $41 million in new federal funding, Mayo Clinic researchers and colleagues from 13 other institutions around the country are pursuing three multiethnic projects to identify targets for treatment.

Released: 27-Mar-2023 11:05 AM EDT
UC Davis Health collaborates with Propeller Health to improve clinical outcomes of COPD patients
UC Davis Health (Defunct)

A new collaboration between UC Davis Health and Propeller Health will offer personalized treatment for high-risk patients with asthma and chronic obstructive pulmonary disease.

Released: 21-Mar-2023 7:25 PM EDT
Machine learning programs predict risk of death based on results from routine hospital tests
University of Alberta

Hospital ECGs are usually read by a doctor or nurse at your bedside, but now researchers are using artificial intelligence to glean even more information from those results to improve your care and the health-care system all at once.

   

Not for public release

This news release is embargoed until 20-Mar-2023 4:15 PM EDT Released to reporters: 27-Jul-2022 1:40 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-Mar-2023 4:15 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

       
Released: 20-Mar-2023 9:00 AM EDT
Antibiotic resistance is an increasing problem. Learn all about it in the Drug Resistance channel.
Newswise

Staphylococcus aureus, Clostridioides difficile, Candida auris, Drug-resistant Shigella. These bacteria not only have difficult names to pronounce, but they are also difficult to fight off. These bacteria may infect humans and animals, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Antimicrobial resistance is an urgent global public health threat.

     
Released: 16-Mar-2023 7:25 PM EDT
An extra X chromosome-linked gene may explain decreased viral infection severity in females
University of California, Los Angeles (UCLA), Health Sciences

Researchers may have found why viral infections hit males more severely than females. They found that female mouse and human NK cells have an extra copy of an X chromosome-linked gene called UTX. UTX acts as an epigenetic regulator to boost NK cell anti-viral function, while repressing NK cell numbers.

   
Released: 16-Mar-2023 9:00 AM EDT
Ochsner Health Advances Precision Medicine, Becomes National Leader in Universal Genomic Testing for Chemotherapy
Ochsner Health

Ochsner Health is leading the way for precision medicine nationwide by becoming one of the first hospital systems to standardize genomic testing, significantly advancing ways in which care teams can treat cancer patients. This change helps providers determine individualized treatment by understanding how patients will react to certain drugs, thereby lowering risk of adverse side effects, improving patient experience, and bettering patient outcomes.

Released: 15-Mar-2023 5:55 PM EDT
Physical exercise helps to improve symptoms of Parkinson’s Disease
Cochrane

Physical exercise can help to improve the severity of movement-related symptoms and the quality of life in people with Parkinson’s Disease. Findings from the first Cochrane review of the available evidence found that any type of structured exercise is better than none.

Released: 15-Mar-2023 3:45 PM EDT
Don't keep hitting that snooze button! Get the latest research news and expert commentary on sleep here.
Newswise

It's sleep awareness week, according to the National Sleep Foundation. It’s important to understand how sleep deprivation can impact your health. Most people recognize that if they don’t get enough sleep, their mood and memory will suffer the next day.

       
Newswise: PCORI Awards Researchers $10.2 Million to Study Individualized Model of Hemodialysis
Released: 9-Mar-2023 10:05 AM EST
PCORI Awards Researchers $10.2 Million to Study Individualized Model of Hemodialysis
Wake Forest University School of Medicine

The Patient-Centered Outcomes Research Institute (PCORI) recently awarded researchers at Wake Forest University School of Medicine $10.2 million to study the effectiveness of an individualized model of hemodialysis, a procedure in which the blood is cleaned by a dialysis machine. The project is a collaboration between the School of Medicine, the Renal Research Institute and other health care systems across the country.

Released: 2-Mar-2023 7:00 AM EST
Pesquisadores da Mayo Clinic relacionam o câncer de ovário com a colonização de bactérias no microbioma
Mayo Clinic

Uma colonização específica de micróbios no trato reprodutivo é comumente encontrada em mulheres com câncer de ovário de acordo com um novo estudo do Centro de Medicina Individualizada da Mayo Clinic. A descoberta, publicada na revista Scientific Reports, fortalece a evidência de que o componente bacteriano do microbioma (uma comunidade de microrganismos que também consistem em vírus, leveduras e fungos) é um importante indicador para detecção precoce, diagnóstico e prognóstico do câncer de ovário.

Released: 2-Mar-2023 7:00 AM EST
Los investigadores de Mayo Clinic vinculan el cáncer de ovario con la colonización bacteriana en el microbioma
Mayo Clinic

Según un nuevo estudio del Centro de Medicina Personalizada en Mayo Clinic, se suele hallar una colonización específica de microbios en el aparato reproductor de las mujeres con cáncer de ovario. Este descubrimiento, publicado en la revista Scientific Reports, refuerza las pruebas de que el componente bacteriano del microbioma (una comunidad de microorganismos que incluye virus, hongos y levaduras) es un indicador importante para la detección temprana, el diagnóstico y el pronóstico del cáncer de ovario.

Newswise: Cancer: In Italy every year over 8000 patients candidate for liquid biopsy
Released: 21-Feb-2023 10:10 PM EST
Cancer: In Italy every year over 8000 patients candidate for liquid biopsy
Sbarro Health Research Organization (SHRO)

SHRO Founder Antonio Giordano contributes to a new publication on the use of liquid biopsy to assess the treatment response and find mutations that confer resistance to cancer therapies.

Released: 21-Feb-2023 2:05 PM EST
A New Catalyst For Recycling Plastic, New Antioxidants Found In Meat, And Other Chemical Research News
Newswise

Below are some of the latest articles that have been added to the Chemistry news channel on Newswise.

Released: 31-Jan-2023 5:05 PM EST
The latest research news on surgery and transplants
Newswise

Below are some of the latest articles that have been added to the Surgery and the Transplantation channels on Newswise, a free source for journalists.

Newswise: Johns Hopkins Physicians and Engineers Develop Search for AI Program That Accurately Predicts Risk of 'ICU Delirium'
Released: 26-Jan-2023 11:00 AM EST
Johns Hopkins Physicians and Engineers Develop Search for AI Program That Accurately Predicts Risk of 'ICU Delirium'
Johns Hopkins Medicine

More than one-third of all people admitted to the hospital, and as many as 80% of all patients in an intensive care unit (ICU), develop delirium, a type of brain dysfunction marked by sudden bouts of confusion, inattention, paranoia, or even agitation and hallucinations. An intensivist at Johns Hopkins Medicine, in collaboration with Johns Hopkins University engineering students, report they have developed artificial intelligence (AI) algorithms that can detect the early warning signs of delirium and can predict — at any time during an ICU stay — a high risk of delirium for a significant number of patients.

Released: 26-Jan-2023 9:05 AM EST
Investigadores de Mayo Clinic diseñan vacunas terapéuticas personalizadas para combatir el cáncer  
Mayo Clinic

Las vacunas han protegido a las personas de enfermedades mortales durante generaciones. ¿También podrían ayudar a combatir el cáncer? Los investigadores de Mayo Clinic están trabajando en el desarrollo de vacunas terapéuticas personalizadas contra el cáncer que podrían atacar las características distintivas de los tumores en cada persona.

Released: 26-Jan-2023 9:05 AM EST
Pesquisadores da Mayo Clinic desenvolvem vacinas terapêuticas personalizadas para combater o câncer  
Mayo Clinic

As vacinas protegem as pessoas contra doenças mortais ao longo de gerações, mas será que elas também poderiam ajudar a combater o câncer? Os pesquisadores da Mayo Clinic estão trabalhando para desenvolver vacinas terapêuticas personalizadas contra o câncer.

Released: 26-Jan-2023 12:05 AM EST
باحثو مايو كلينك يصممون لقاحات علاجية مخصصة لمكافحة السرطان
Mayo Clinic

جاكسونفيل، فلوريدا — لطالما حمت اللقاحات الناس من الأمراض الفتاكة لأجيال. فهل يمكنها أيضًا المساعدة في محاربة السرطان؟  يعمل باحثو مايو كلينك على تطوير لقاحات علاجية مخصصة للسرطان يمكنها استهداف خصائص الورم المميزة لكل شخص. إن هذا النهج الجديد، المبني على التقدم في الأبحاث الجينومية وتحليلات البيانات، يحمل إمكانات تحويلية لتعزيز قوة الجهاز المناعي للتعرف على الخلايا السرطانية ومهاجمتها. 

Newswise: Malfunctioning Mitochondria at the Heart of Many Cardiovascular Diseases
Released: 23-Jan-2023 11:05 AM EST
Malfunctioning Mitochondria at the Heart of Many Cardiovascular Diseases
Sbarro Health Research Organization (SHRO)

Many cardiovascular diseases, such as atherosclerosis, or ‘hardening of the arteries,’ correlate to mitochondrial dysfunction and endothelial impairment in the tissues of the heart and blood vessels.

Released: 23-Jan-2023 9:00 AM EST
BillionToOne appoints Dr. Gary Palmer as Chief Medical Officer, Oncology; Launches Northstar Select™ and Northstar Response™ Liquid Biopsy Assays for Commercial Use
BillionToOne

Dr. Palmer brings significant expertise both as a clinical oncologist and as a high-level executive at several national laboratories. His prior industry roles include CMO at Tempus Labs, VP of Medical Affairs at Foundation Medicine, and VP of Medical Affairs at Genomic Health.

Released: 19-Jan-2023 11:05 AM EST
Mayo Clinic researchers identify women with twice the risk of cancer in both breasts
Mayo Clinic

Women with cancer in one breast may be at higher risk of developing cancer in the opposite breast if they are carriers of specific genetic changes that predispose them to develop breast cancer, according to a study led by the Mayo Clinic Comprehensive Cancer Center. The findings, published in the Journal of Clinical Oncology, will help personalize approaches to breast cancer screening and risk factors, study authors say.

Released: 16-Jan-2023 5:45 PM EST
Using machine learning to predict brain tumor progression
University of Waterloo

Researchers at the University of Waterloo have created a computational model to predict the growth of deadly brain tumours more accurately.

   
Newswise: Consider risks and alternatives before deciding on LASIK surgery, UT Southwestern ophthalmologists say
Released: 13-Jan-2023 11:10 AM EST
Consider risks and alternatives before deciding on LASIK surgery, UT Southwestern ophthalmologists say
UT Southwestern Medical Center

Patients considering LASIK vision correction surgery should weigh the risks as well as benefits and see a doctor who can assess whether they are a good candidate for the procedure, according to an ophthalmologist at UT Southwestern Medical Center.

Released: 27-Dec-2022 7:10 PM EST
Unlocking cancer’s ancestry
Cold Spring Harbor Laboratory

Could knowing where your ancestors came from be the key to better cancer treatments? Maybe, but where would that key fit? How can we trace cancer’s ancestral roots to modern-day solutions?

Released: 20-Dec-2022 2:50 PM EST
Komen Advocates Will Play Critical Role in Shaping Future Breast Cancer Care Through Partnership with Guardant Health
Susan G. Komen

Susan G. Komen and Guardant Health have formed a new partnership to help improve breast cancer outcomes by including the input of patient advocates. These advocates, who serve as Susan G. Komen Advocates in Science, will provide a first-hand understanding of what matters most to patients in the development of research studies to find more effective ways to care for patients with early-stage breast cancer.

Released: 20-Dec-2022 9:35 AM EST
CEFALY Technology Launches Trade-In Program for Purchasers of the New CEFALY Connected Migraine Treatment Device
Cefaly Technology

Medical device maker CEFALY Technology has announced that owners of older CEFALY devices can trade them in for credit toward the purchase of the all-new CEFALY Connected.

   
Newswise: Scientists have proposed a more efficient combination of evaluating drug concentrations
Released: 19-Dec-2022 6:05 AM EST
Scientists have proposed a more efficient combination of evaluating drug concentrations
Scientific Project Lomonosov

Scientists at Baltic Federal University have suggested evaluating concentration and chemical composition of drugs by means of vibrational spectroscopy and nuclear magnetic resonance instead of conventional complex approaches

   
Newswise: Investigators Develop Model to Predict Overall Survival in Adults Diagnosed with Advanced Stage Hodgkin Lymphoma
6-Dec-2022 10:05 AM EST
Investigators Develop Model to Predict Overall Survival in Adults Diagnosed with Advanced Stage Hodgkin Lymphoma
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey and Tufts Medical Center Collaboration Published in Journal of Clinical Oncology

Released: 2-Dec-2022 6:30 PM EST
No ‘one size fits all’ solution to treating early-onset psychosis
University of Birmingham

Gold standard treatment plans for people with early psychosis have a patchy success rate, suggesting the need to develop more tailored approaches.

Newswise: Do women age differently from men?
Released: 1-Dec-2022 7:30 PM EST
Do women age differently from men?
Max Planck Institute for Biology of Ageing

The life expectancy of women is significantly higher than that of men.

29-Nov-2022 10:45 AM EST
New Genetic Mutation Behind Childhood Glaucoma Identified
Massachusetts Eye and Ear

An international team of researchers led by Mass Eye and Ear discovered a new genetic mutation that leads to childhood glaucoma, and in the process uncovered a new mechanism for causing the disease.

Newswise: St. Joseph’s Health and Hackensack Meridian Health: 20th Anniversary of Acute Rehabilitation Unit & One-Year Anniversary of Rehabilitation Partnership
Released: 23-Nov-2022 10:20 AM EST
St. Joseph’s Health and Hackensack Meridian Health: 20th Anniversary of Acute Rehabilitation Unit & One-Year Anniversary of Rehabilitation Partnership
Hackensack Meridian Health

“We are delighted to celebrate the one year anniversary of our rehabilitation clinical affiliation with St. Joseph’s Health,” said Robert C. Garrett, FACHE, CEO, Hackensack Meridian Health. “Throughout the state, our rehab experts have been improving lives through their vast expertise in healing and restoring quality of life after a serious illness or traumatic episode. This affiliation has placed our advanced services closer to home for residents of Northern New Jersey.”

Released: 22-Nov-2022 7:20 PM EST
New study brings personalized immunotherapy prescriptions a step closer
University of Bath

In a step likely to advance personalised cancer treatment, scientists have for the first time shown in patients that levels of biomarkers are not enough to tell which patients are likely to respond best to immunotherapy.

Newswise: Wearable Activity Trackers Can Be Used to Determine Health Metrics That Could Support Clinical Care
Released: 17-Nov-2022 12:00 PM EST
Wearable Activity Trackers Can Be Used to Determine Health Metrics That Could Support Clinical Care
Johns Hopkins Medicine

A new Johns Hopkins study shows that data gathered from wearable activity trackers can be used to obtain several metrics associated with the user’s general physical health and cardiovascular health status.

Newswise: KU Medical Center researchers receive R01 grant from National Cancer Institute to increase targeted cancer treatments to rural cancer patients
Released: 16-Nov-2022 2:40 PM EST
KU Medical Center researchers receive R01 grant from National Cancer Institute to increase targeted cancer treatments to rural cancer patients
University of Kansas Cancer Center

TEAMSPORT will create a standardized approach to ordering genomic tests and adapt it for use in community cancer centers, where most cancer patients receive testing and treatment.



close
1.13239